Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Net Cash Flow (2016 - 2025)

Plus Therapeutics has reported Net Cash Flow over the past 16 years, most recently at -$4.5 million for Q4 2025.

  • Quarterly Net Cash Flow fell 296.6% to -$4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, up 202.41% year-over-year, with the annual reading at $8.7 million for FY2025, 202.41% up from the prior year.
  • Net Cash Flow was -$4.5 million for Q4 2025 at Plus Therapeutics, down from $11.1 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $11.1 million in Q3 2025 and troughed at -$7.6 million in Q2 2025.
  • The 5-year median for Net Cash Flow is -$1.8 million (2023), against an average of -$208294.1.
  • Year-over-year, Net Cash Flow skyrocketed 498.5% in 2021 and then plummeted 3423.42% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $6.1 million in 2021, then tumbled by 135.17% to -$2.1 million in 2022, then fell by 14.26% to -$2.5 million in 2023, then skyrocketed by 53.22% to -$1.1 million in 2024, then plummeted by 296.6% to -$4.5 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Net Cash Flow are -$4.5 million (Q4 2025), $11.1 million (Q3 2025), and -$7.6 million (Q2 2025).